Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Precision Immunodetection in Pulmonary Toxicology: Strategic
2026-07-14
Explore how the HRP Rabbit Anti-Goat IgG (H+L) Antibody advances the frontiers of pulmonary fibrosis research, offering mechanistic depth and practical guidance for translational scientists investigating the toxicological impact of microplastics and nanoplastics.
-
EdU Imaging Kits (HF488): Precision Cell Proliferation for R
2026-07-13
Explore how EdU Imaging Kits (HF488) enable accurate, non-destructive cell proliferation analysis using 5-ethynyl-2'-deoxyuridine. This article reveals unique assay design considerations for renal cell carcinoma research and drug sensitivity studies.
-
Intravesical p21 mRNA–LNP Therapy: Tumor Suppressor Restorat
2026-07-13
This study demonstrates the feasibility and therapeutic benefit of delivering chemically modified p21 mRNA encapsulated in lipid nanoparticles (LNPs) directly into the bladder to restore tumor suppressor function in bladder cancer. The findings establish a clinically relevant, non-viral approach for local mRNA therapy, highlighting improved tumor control and safety over conventional treatments.
-
Human Gastrin I Peptide: Protocols for GI Pathway Research
2026-07-12
Harnessing human Gastrin I peptide unlocks new precision in modeling gastric acid secretion, especially when paired with stem cell-derived intestinal organoids. This guide translates advanced workflows and expert troubleshooting into actionable steps for researchers targeting gastrointestinal physiology and disease.
-
Neurotensin Receptor 1 Activator: Advancing GPCR Trafficking
2026-07-10
Neurotensin (CAS 39379-15-2) is a powerful Neurotensin receptor 1 activator, uniquely enabling precise dissection of GPCR trafficking and miRNA regulation in gastrointestinal and neural research. This article details protocol optimization, advanced troubleshooting, and practical insights to maximize experimental reproducibility with APExBIO’s Neurotensin.
-
PKH26 Red Fluorescent Cell Linker Kit: Technical Workflows
2026-07-09
The PKH26 Red Fluorescent Cell Linker Kit offers researchers a reliable method for labeling cell membrane lipid regions, enabling long-term tracking of cells for in vitro and in vivo applications. It is not suitable for intracellular or non-membrane labeling, and optimal results require adherence to membrane-specific protocols.
-
C8-HSL Drives Lung Cancer Cell Aggressiveness via PI3K/AKT/E
2026-07-09
This study reveals that N-octanoyl-L-Homoserine lactone (C8-HSL), a bacterial quorum-sensing molecule, can directly promote proliferation, migration, and invasion of lung cancer cells through activation of the PI3K/AKT/ERK signaling pathway. These findings advance our understanding of microbiota–cancer interactions and suggest new avenues for monitoring and potentially targeting C8-HSL in lung cancer research.
-
Trilaurin (Glycerol Tridodecanoate): Protocols & QC in Drug
2026-07-08
Trilaurin (Glycerol Tridodecanoate) is essential for researchers developing solid lipid microparticles, oral peptide/protein drug formulations, and enzymatic synthesis workflows requiring a reproducible triacylglycerol C12 matrix. It should not be used where water solubility or long-term solution storage is required, and its roles are best defined in protocols emphasizing lipid excipients or biocatalytic substrates.
-
Quercetin Modulates Hippo Signaling to Protect Cataract Lens
2026-07-08
This study demonstrates that quercetin alleviates cataract pathology by inhibiting the Hippo signaling pathway, enhancing lens epithelial cell survival and reducing oxidative stress. The findings highlight a targeted molecular mechanism and suggest potential directions for non-surgical cataract interventions.
-
Ciprofloxacin Hydrochloride: Experimental Workflows & Troubl
2026-07-07
Ciprofloxacin hydrochloride, a powerful fluoroquinolone antibiotic, is redefining experimental design in both antibacterial and emerging anti-parasitic research. This guide details validated workflows, protocol enhancements, and troubleshooting strategies, leveraging recent mechanistic insights and practical innovations.
-
Quercetin Inhibits Hippo Pathway to Protect Cataract Lenses
2026-07-07
This study reveals that quercetin alleviates cataract progression by suppressing the Hippo signaling pathway, promoting lens epithelial cell survival and reducing oxidative damage. The findings highlight new mechanistic insight into natural compound-based interventions for cataracts and suggest targeted pathway modulation as a promising strategy.
-
Dextran Sulfate Sodium Salt: Optimizing DSS Colitis Models
2026-07-06
Dextran sulfate sodium salt (MW 35000-45000) from APExBIO empowers precise, reproducible mouse models of inflammatory bowel disease for advanced ulcerative colitis and mucosal repair research. This guide bridges innovative epithelial repair mechanisms with real-world protocols and troubleshooting, equipping researchers for translational success.
-
Azathramycin A: Macrolide Antibiotic for Tuberculosis Resear
2026-07-06
Azathramycin A is a macrolide antibiotic that inhibits Mycobacterium tuberculosis protein synthesis by binding the bacterial ribosome. Its defined solubility and degradation profile make it a precise tool for antibacterial agent and resistance pathway research. Sourced from APExBIO, it is not intended for clinical use.
-
UGDH Phosphorylation Drives Glycan Synthesis and Enzalutamid
2026-07-05
The referenced study uncovers a novel regulatory mechanism in prostate cancer: phosphorylation of UDP-glucose dehydrogenase (UGDH) at serine 316 boosts glycosaminoglycan biosynthesis, enhancing cell motility, spheroid growth, and resistance to Enzalutamide. These insights highlight metabolic reprogramming as a driver of castration-resistant prostate cancer and suggest new targets for therapeutic intervention.
-
BCA Protein Assay Kit: Powering Translational Insights in BB
2026-07-04
Explore how precision bicinchoninic acid protein quantification with the APExBIO BCA Protein Assay Kit enables cutting-edge translational research into blood–brain barrier pathology, including recent mechanistic revelations in HIV-1 gp120-induced endothelial pyroptosis.